Camson Biotech net profit jumps 162 pc in Q4 FY11

MUMBAI: Camson Biotechnologies Ltd, one of the leading IPR-driven biotechnology companies, posted 162 per cent jump in net profit at Rs 6.18 crore in the fourth quarter ended March, 2011 from Rs 2.36 crore in the same quarter last year.

The company declared a total income of Rs 99.14 crore for the year ended March 31 2011, rising 24 per cent YoY from Rs 80 crore in the corresponding period last year, a company statement said here.

The company has attributed strong growth to increased demand and better realisations for its zero-residue biocides and unique hybrid seeds.

"Our main goal was to provide farmers with a sustainable livelihood and a platform to produce eco-friendly yield. We will now focus on our marketing and branding programs for biocides and seeds to ensure that we receive a premium for our products in the long run," Camson's Managing Director, Dhirendra Kumar said.